HCAT's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 0.52 -- higher than only 6.33% of US-listed equities with positive expected earnings growth.
HCAT's went public 1.35 years ago, making it older than merely 1.5% of listed US stocks we're tracking.
With a year-over-year growth in debt of 262.94%, Health Catalyst Inc's debt growth rate surpasses 94.13% of about US stocks.
Stocks with similar financial metrics, market capitalization, and price volatility to Health Catalyst Inc are FEYE, SVMK, LPSN, CLXT, and DMRC.
Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its products include analytics platform, accountable care and financial, benchmarking and comparative analytics, care management and population health, clinical analytics, operations and performance management, patient safety, and services. The company is headquartered in Salt Lake City, Utah.
I covered Health Catalyst (HCAT) when the company went public in the summer of last year. At the time of the offering, I noted that the company seems an interesting play to bet on health care improvements as the company combines data, technology and experts, resulting in rapid growth of...
The Value Investor on Seeking Alpha | August 30, 2020
Health Catalyst, Inc. (HCAT) Q2 2020 Earnings Conference Call Aug 11, 2020 5:00 PM ET Company Participants Adam Brown - SVP, IR Dan Burton - CEO Patrick Nelli - CFO Conference Call Participants Robert Jones - Goldman Sachs Anne Samuel - JPMorgan Ryan Daniels - William Blair Sean Wieland -...